The Corona Study of Middle Norway

NCT05638178 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 223

Last updated 2022-12-06

No results posted yet for this study

Summary

CUT COVID is a cohort study establised to collect information on patients hospitalized because or with infection by SARS-CoV-2. The cohort data includes clinical data and biological samples from multiple timepoints during hospitalization, as well as data from a followup consultation 3 months after discharge.

Conditions

  • SARS-CoV-2 Acute Respiratory Disease
  • SARS-CoV-2 Sepsis
  • SARS CoV 2 Infection

Interventions

OTHER

No intervention

No intervention, cohort study.

Sponsors & Collaborators

  • The Research Council of Norway

    collaborator OTHER
  • Alesund Hospital

    collaborator OTHER
  • Namsos Hospital

    collaborator OTHER
  • Molde Hospital

    collaborator OTHER
  • Helse Nord-Trøndelag HF

    collaborator OTHER
  • St. Olavs Hospital

    lead OTHER

Principal Investigators

  • Kari Risnes, MD/PhD · St. Olavs Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2021-12-31
Completion
2022-08-12

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05638178 on ClinicalTrials.gov